Literature DB >> 3816875

Metabolism of pheneturide in the rat and in man.

J Vachta, K Valter, P Gold-Aubert.   

Abstract

The biotransformation of pheneturide was studied in humans and in the rat. Human volunteers received a single oral dose of 10 mg/kg of pheneturide and the rats were given repeated doses of 250 mg/kg. Urine from both study groups was extracted with Amberlite XAD-2 and the extracts were separated by preparative HPLC after enzymatic hydrolysis. Five metabolites were isolated in man and their structures were determined using NMR and mass spectrometry. The hydrolysis of the ureide function and the 4-hydroxylation of the benzene ring led to the formation of two major metabolites: 2-(4-hydroxyphenyl)-butyroylurea (37.5%) and 2-phenylbutyric acid (40.6%), and to one minor metabolite: 2-(4-hydroxyphenyl)-butyric acid (11.9%). Seven metabolites were isolated in the rat. The 4-hydroxylation of the benzene ring and the C 3 hydroxylation of the aliphatic chain led to the formation of two major metabolites: 2-(4-hydroxyphenyl)-butyroylurea (70.5%) and 3-hydroxy-2-phenyl-butyroylurea (19.6%), whereas the hydrolysis of the ureide function was less important. Only traces of the parent drug were found in humans as well as in the rat.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3816875     DOI: 10.1007/BF03189847

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  7 in total

1.  [Distribution and elimination of labeled pheneturide].

Authors:  B GLASSON; P LERCH; A BENAKIS
Journal:  Therapie       Date:  1960       Impact factor: 2.070

2.  [Contribution to the therapy of epilepsy with acetylureas].

Authors:  R SCHWEINGRUBER; E KETZ
Journal:  Schweiz Med Wochenschr       Date:  1960-04-09

3.  [Experiences with Pheneturid in refractory epilepsy].

Authors:  E Ketz; C Bernoulli; P Gold-Aubert
Journal:  Schweiz Rundsch Med Prax       Date:  1972-09-12

4.  Treatment of intractable temporal lobe epilepsy with pheneturide.

Authors:  C J Vas; M J Parsonage
Journal:  Acta Neurol Scand       Date:  1967       Impact factor: 3.209

5.  Febarbamate: metabolism in the rat.

Authors:  J Vachta; P Gold-Aubert
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1982       Impact factor: 2.441

6.  Pharmacokinetics of phenylethylacetylurea (pheneturide), an old antiepileptic drug.

Authors:  R L Galeazzi; M Egli; N Wad
Journal:  J Pharmacokinet Biopharm       Date:  1979-10

7.  Febarbamate: metabolism in man.

Authors:  J Vachta; K Valter; P Gold-Aubert
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1983 Jul-Sep       Impact factor: 2.441

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.